Current Practice in obstetric anaesthesia I. – peri-operative care in Caesarean Section

1. van Dongen, P. W. J. Caesarean Section – Etymology and Early History. South African Journal of Obstetrics and Gynaecology, 2009, 15, 2, p. 62–66.

2. Pařízek, A., Bláha, J., Dolenská, S., Nosková, P. Aktuální vývoj porodnické analgézie v ČR. In: XVII národní kongres ČSARIM: 10.9.2010, Zlín, 2010.

3. Štourač, P., Bláha, J., Klozová, R., Nosková, P., Seidlová, P. OBAAMA – jak je na tom současná česká porodnická anestezie. In: XIX kongres České společnosti anesteziologie, resuscitace a intenzivní medicíny. Hradec Králové, 2012.

4. Oppenheimer, L. Diagnosis and management of placenta previa. Journal of obstetrics and gynaecology Canada (JOGC) 2007, 29, 3, p. 261–273.

5. Visalyaputra, S., Rodanant, O., Somboonviboon, W., Tantivitayatan, K., Thienthong, S., Saengchote, W. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study. Anesthesia and analgesia, 2005, 101, 3, p. 862–868, table of contents.

6. Rahman, K., Jenkins, J. G. Failed tracheal intubation in obstetrics: no more frequent but still managed badly. Anaesthesia, 2005, 60, 2, p. 168–171.

7. McDonnell, N. J., Paech, M. J., Clavisi, O. M., Scott, K. L. Difficult and failed intubation in obstetric anaesthesia: an observational study of airway management and complications associated with general anaesthesia for caesarean section. Int. J. Obstet. Anesth., 2009, 17, 4, p. 292–297.

8. Lyons, G., Akerman, N. Problems with general anaesthesia for Caesarean section. Minerva Anestesiol., 2005, 71, 1–2, p. 27–38.

9. Barnardo, P. D., Jenkins, J. G. Failed tracheal intubation in obstetrics: a 6-year review in a UK region. Anaesthesia, 2000, 55, 7, p. 690–694.

10. Hawkins, J. L. Anesthesia-related maternal mortality. Clin. Obstet. Gynecol., 2003, 46, 3, p. 679–687.

11. Afolabi, B. B., Lesi, F. E., Merah, N. A. Regional versus general anaesthesia for caesarean section. Cochrane Database Syst. Rev., 2006, 4, CD004350.

12. Reynolds, F., Seed, P. T. Anaesthesia for Caesarean section and neonatal acid-base status: a meta-analysis. Anaesthesia, 2005, 60, 7, p. 636–653.

13. Sigalas, J., Galazios, G., Tsikrikoni, I., Scordala, M., Vogiatjaki, T., Spanopoulou, P. I., Tsikouras, P. The influence of the mode of anaesthesia in the incidence of neonatal morbidity after an elective caesarean section. Clin. Exp. Obstet. Gynecol., 2006, 33, 1, p. 10–12.

14. Jain, K., Bhardwaj, N., Sharma, A., Kaur, J., Kumar, P. A randomised comparison of the effects of low-dose spinal or general anaesthesia on umbilical cord blood gases during caesarean delivery of growth-restricted foetuses with impaired Doppler flow. European journal of anaesthesiology, 2012.

15. Algert, C. S., Bowen, J. R., Giles, W. B., Knoblanche, G. E., Lain, S. J., Roberts, C. L. Regional block versus general anaesthesia for caesarean section and neonatal outcomes: a population--based study. BMC medicine, 2009, 7, p. 20.

16. Mancuso, A., De Vivo, A., Giacobbe, A., Priola, V., Maggio Savasta, L., Guzzo, M., De Vivo, D. General versus spinal anaesthesia for elective caesarean sections: effects on neonatal short--term outcome. A prospective randomised study. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet, 2010, 23, 10, p. 1114–1118.

17. Laudenbach, V., Mercier, F. J., Roze, J. C., Larroque, B., Ancel, P. Y., Kaminski, M., Breart, G., Diemunsch, P., Subtil, D., Lejus, C. et al. Anaesthesia mode for caesarean section and mortality in very preterm infants: an epidemiologic study in the EPIPAGE cohort. International journal of obstetric anesthesia, 2009, 18, 2, p. 142–149.

18. Liu, S. S., McDonald, S. B. Current issues in spinal anesthesia. Anesthesiology, 2001, 94, 5, p. 888–906.

19. Lee, A., Ngan Kee, W. D., Gin, T. A dose-response meta-analysis of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for elective cesarean delivery. Anesthesia and analgesia, 2004, 98, 2, p. 483–490, table of contents.

20. Popham, P., Buettner, A., Mendola, M. Anaesthesia for emergency caesarean section, 2000-2004, at the Royal Women‘s Hospital, Melbourne. Anaesth. Intensive Care, 2007, 35, 1, p. 74–79.

21. Kinsella, S. M., Girgirah, K., Scrutton, M. J. Rapid sequence spinal anaesthesia for category-1 urgency caesarean section:a case series. Anaesthesia, 2010, 65, 7, p. 664–669.

22. Dahl, V., Spreng, U. J. Anaesthesia for urgent (grade 1) caesarean section. Current opinion in anaesthesiology, 2009, 22, 3, p. 352–356.

23. Hillyard, S. G., Bate, T. E., Corcoran, T. B., Paech, M. J., O‘Sullivan, G. Extending epidural analgesia for emergency Caesarean section: a meta-analysis. British journal of anaesthesia, 2011, 107, 5, p. 668–678.

24. Tanoubi, I., Drolet, P., Donati, F. Optimizing preoxygenation in adults. Canadian journal of anaesthesia, 2009, 56, 6, p. 449–466.

25. Farmery, A. D., Roe, P. G. A model to describe the rate of oxyhaemoglobin desaturation during apnoea. British journal of anaesthesia, 1996, 76, 2, p. 284–291.

26. Benumof, J. L., Dagg, R., Benumof, R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology, 1997, 87, 4, p. 979–982.

27. Tanoubi, I. Oxygenation before anesthesia (preoxygena-tion) in adults. In Anesthesiology Rounds, vol. 5. Department of Anesthesiology, University of Montreal, 2006.

28. Cogliano, M. S., Graham, A. C., Clark, V. A. Supplementary oxygen administration for elective Caesarean section under spinal anaesthesia. Anaesthesia, 2002, 57, 1, p. 66–69.

29. Khaw, K. S., Wang, C. C., Ngan Kee, W. D., Pang, C. P., Rogers, M. S. Effects of high inspired oxygen fraction during elective caesarean section under spinal anaesthesia on maternal and fetal oxygenation and lipid peroxidation. Br. J. Anaesth., 2002, 88, 1, p. 18–23.

30. Khaw, K. S., Ngan Kee, W. D. Fetal effects of maternal supplementary oxygen during Caesarean section. Curr. Opin. Anaesthesiol., 2004, 17, 4, p. 309–313.

31. Thorp, J. A., Trobough, T., Evans, R., Hedrick, J., Yeast, J. D. The effect of maternal oxygen administration during the second stage of labor on umbilical cord blood gas values: a randomized controlled prospective trial. Am. J. Obstet. Gynecol., 1995, 172, 2 Pt 1, p. 465–474.

32. Khazin, A. F., Hon, E. H., Hehre, F. W. Effects of maternal hyperoxia on the fetus. I. Oxygen tension. Am. J. Obstet. Gynecol., 1971, 109, 4, p. 628–637.

33. Buhimschi, I. A., Buhimschi, C. S., Pupkin, M., Weiner, C. P.Beneficial impact of term labor: nonenzymatic antioxidant reserve in the human fetus. Am. J. Obstet. Gynecol., 2003, 189, 1, p. 181–188.

34. Lyons, G. Saving mothers‘ lives: confidential enquiry into maternal and child health 2003-5. International journal of obstetric anesthesia, 2008, 17, 2, p. 103–105.

35. James, A. H. Prevention and management of venous thromboembolism in pregnancy. The American journal of medicine, 2007, 120, 10 Suppl 2, S26–34.

36. Kujovich, J. L. Hormones and pregnancy: thromboembolic risks for women. Br. J. Haematol., 2004, 126, 4, p. 443–454.

37. Heit, J. A., Kobbervig, C. E., James, A. H., Petterson, T. M., Bailey, K. R., Melton, L. J. 3rd Trends in the incidence of venous thrombo-embolism during pregnancy or postpartum: a 30-year population-based study. Annals of internal medicine, 2005, 143, 10, p. 697–706.

38. Pomp, E. R., Lenselink, A. M., Rosendaal, F. R., Doggen, C. J.Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. Journal of thrombosis and haemostasis (JTH), 2008, 6, 4, p. 632–637.

39. James, A. H. Pregnancy and thrombotic risk. Crit. Care Med., 2010, 38, 2 Suppl, S57–63.

40. Buhimschi, C. S., Buhimschi, I. A., Abdel-Razeq, S., Rosenberg, V. A., Thung, S. F., Zhao, G., Wang, E., Bhandari, V. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatric research, 2007, 61, 3, p. 318–324.

41. Mahieu, B., Jacobs, N., Mahieu, S., Naelaerts, K., Vertessen, F., Weyler, J., Jacquemyn, Y., Van der Planken, M. Haemostatic changes and acquired activated protein C resistance in normal pregnancy. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis, 2007, 18, 7, p. 685–688.

42. Brenner, B. Haemostatic changes in pregnancy. Thrombosis research, 2004, 114, 5–6, p. 409–414.

43. Johnson, R. F., Herman, N. L., Johnson, H. V., Arney, T. L., Paschall, R. L., Downing, J. W. Effects of fetal pH on local anesthetic transfer across the human placenta. Anesthesiology, 1996, 85, 3, p. 608–615.

44. Start, R. J., Greenberg, D. J., Herman, N. L. Use of a Wilson Convex Frame in removing „irretrievable“ epidural catheters. Anesthesia and analgesia, 1992, 75, 2, p. 305–306.

45. Widimský, J., Malý, J., Eliáš, P., Lang, O., Franc, P., Roz-točil, K. Doporučení diagnostiky, léčby a prevence plicní embolie. Vnitr. Lek., 2008, 54, Suppl 1, S25–S72.

46. Horlocker, T. T., Wedel, D. J., Rowlingson, J. C., Enneking, F. K., Kopp, S. L., Benzon, H. T., Brown, D. L., Heit, J. A., Mulroy, M. F., Rosenquist, R. W. et al. Regional anesthesia in the pa-tient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence--Based Guidelines (Third Edition). Reg. Anesth. Pain Med., 2010, 35, 1, p. 64–101.

47. Marik, P. E. Venous thromboembolism in pregnancy. Clinics in chest medicine, 2010, 31, 4, p. 731–740.

48. Rosenberg, V. A., Lockwood, C. J. Thromboembolism in pregnancy. Obstetrics and gynecology clinics of North America, 2007, 34, 3, p. 481–500.

49. Kunar, M. A., Humphreys, G. W., Smith, K. J., Watson, D. G. When a reappearance is old news: visual marking survives occlusion. Journal of experimental psychology Human perception and performance, 2003, 29, 1, p. 185–198.

50. Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., Smith, K. J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Annals of neurology, 2003, 53, 2, p. 174–180.

51. Bates, S. M., Greer, I. A., Hirsh, J., Ginsberg, J. S. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126, 3 Suppl., p. 627S–644S.

52. Hull, R. D., Pineo, G. F., MacIsaac, S. Low-molecular-weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery. Thrombosis research, 2001, 101, 1, p. V155–162.

53. Strebel, N., Prins, M., Agnelli, G., Buller, H. R. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Archives of internal medicine, 2002, 162, 13, p. 1451–1456.

54. Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., Colwell, C. W. Prevention of venous thromboembolism: American College of Chest Physicians Evidence--Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133, 6 Suppl., p. 381S–453S.

55. Huo, M. H., Spyropoulos, A. C. The eighth American college of chest physicians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies. J. Thromb. Thrombolysis, 2011, 31, 2, p. 196–208.

56. AWMF-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). Dostupné na: http://www.awmf.org/leitlinien/detail/ll/003-001.html.

57. Sia, W. W., Powrie, R. O., Cooper, A. B., Larson, L., Phipps, M., Spencer, P., Sauve, N., Rosene-Montella, K. The incidence of deep vein thrombosis in women undergoing cesarean delivery. Thrombosis research, 2009, 123, 3, p. 550–555.

58. Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., Hirsh, J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133, 6 Suppl., p. 844S–886S.

59. RCOG: Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk (Green-top 37a).

60. Cyna, A. M., Andrew, M., Emmett, R. S., Middleton, P., Simmons, S. W. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst. Rev., 2006, 4, CD002251.

61. Rout, C. C., Rocke, D. A., Levin, J., Gouws, E., Reddy, D. A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective Cesarean section. Anesthesiology, 1993, 79, 2, p. 262–269.

62. Wennberg, E., Frid, I., Haljamae, H., Wennergren, M., Kjellmer, I. Comparison of Ringer‘s acetate with 3% dextran 70 for volume loading before extradural caesarean section. Br. J. Anaesth., 1990, 65, 5, p. 654–660.

63. Butwick, A., Carvalho, B. The effect of colloid and crystalloid preloading on thromboelastography prior to Cesarean delivery. Can. J. Anaesth., 2007, 54, 3, p. 190–195.

64. Crino, J. P., Harris, A. P., Parisi, V. M., Johnson, T. R. Effect of rapid intravenous crystalloid infusion on uteroplacentalblood flow and placental implantation-site oxygen delivery in the pregnant ewe. Am. J. Obstet. Gynecol., 1993, 168, 5, p. 1603–1609.

65. Dyer, R. A., Farina, Z., Joubert, I. A., Du Toit, P., Meyer, M., Torr, G., Wells, K., James, M. F. Crystalloid preload versus rapid crystalloid administration after induction of spinal anaesthesia (coload) for elective caesarean section. Anaesth. Intensive Care, 2004, 32, 3, p. 351–357.

66. Teoh, W. H., Sia, A. T. Colloid preload versus coload for spinal anesthesia for cesarean delivery: the effects on maternal cardiac output. Anesthesia and analgesia, 2009, 108, 5, p. 1592–1598.

67. Carvalho, B., Mercier, F. J., Riley, E. T., Brummel, C.,Cohen, S. E. Hetastarch co-loading is as effective as pre-loading for the prevention of hypotension following spinal anesthesia for cesarean delivery. International journal of obstetric anesthesia, 2009, 18, 2, p. 150–155.

68. Siddik-Sayyid, S. M., Nasr, V. G., Taha, S. K., Zbeide, R. A., Shehade, J. M., Al Alami, A. A., Mokadem, F. H., Abdallah, F. W., Baraka, A. S., Aouad, M. T. A randomized trial comparing colloid preload to coload during spinal anesthesia for elective cesarean delivery. Anesthesia and analgesia, 2009, 109, 4, p. 1219–1224.

69. Ueyama, H., He, Y. L., Tanigami, H., Mashimo, T., Yoshiya, I.Effects of crystalloid and colloid preload on blood volume in the parturient undergoing spinal anesthesia for elective Cesarean section. Anesthesiology, 1999, 91, 6, p. 1571–1576.

70. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology, 2007, 106, 4, p. 843–863.

71. de La Chapelle, A., Benoit, S., Bouregba, M., Durand-Reville, M., Raucoules-Aime, M. The treatment of severe pulmonary edema induced by beta adrenergic agonist tocolytic therapywith continuous positive airway pressure delivered by face mask. Anesth. Analg., 2002, 94, 6, p. 1593–1594, table of contents.

72. Ngan Kee, W. D. Prevention of maternal hypotension after regional anaesthesia for caesarean section. Curr. Opin. Anaesthesiol., 2010, 23, 3, p. 304–309.

73. Ngan Kee, W. D., Khaw, K. S., Ng, F. F. Prevention of hypotension during spinal anesthesia for cesarean delivery: an effective technique using combination phenylephrine infusion and crystalloid cohydration. Anesthesiology, 2005, 103, 4, p. 744–750.

74. Wee, M. Y., Brown, H., Reynolds, F. The National Institute of Clinical Excellence (NICE) guidelines for caesarean sections: implications for the anaesthetist. Int. J. Obstet. Anesth., 2005, 14, 2, p. 147–158.

75. Bamber, J. H., Dresner, M. Aortocaval compression in pregnancy: the effect of changing the degree and direction of lateral tilt on maternal cardiac output. Anesth. Analg., 2003, 97, 1, p. 256–258, table of contents.

76. Magee, L. A., von Dadelszen, P. The management of severe hypertension. Seminars in perinatology, 2009, 33, 3, p. 138–142.

77. Magee, L. A., Lowe, S., Douglas, M. J., Kathirgamanathan, A.Therapeutics and anaesthesia. Best practice & research Clinical obstetrics & gynaecology, 2011, 25, 4, p. 477–490.

78. Vigil-De Gracia, P., Lasso, M., Ruiz, E., Vega-Malek, J. C., de Mena, F. T., Lopez, J. C. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. European journal of obstetrics, gynecology, and reproductive biology, 2006, 128, 1–2, p. 157–162.

79. McCoy, S., Baldwin, K. Pharmacotherapeutic options for the treatment of preeclampsia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, 66, 4, p. 337–344.

80. Podymow, T., August, P. Hypertension in pregnancy. Advan-ces in chronic kidney disease, 2007, 14, 2, p. 178–190.

81. Baggio, M. R., Martins, W. P., Calderon, A. C., Berezowski, A. T., Marcolin, A. C., Duarte, G., Cavalli, R. C. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. Ultrasound in medicine & biology, 2011, 37, 1, p. 53–58.

82. Magee, L. A., Abalos, E., von Dadelszen, P., Sibai, B., Easterling, T., Walkinshaw, S. How to manage hypertension in pregnancy effectively. British journal of clinical pharmacology, 2011, 72, 3, p. 394–401.

83. Chestnut, D. H. (ed.): Obstetric Anesthesia: Principles and Practice, 4 edn. Philadelphia: Mosby, Elsevier Inc., 2009.

84. Podymow, T., August, P. Antihypertensive drugs in pregnancy. Seminars in nephrology, 2011, 31, 1, p. 70–85.

85. Lowe, S. A., Brown, M. A., Dekker, G. A., Gatt, S., McLintock, C. K., McMahon, L. P., Mangos, G., Moore, M. P., Muller, P., Paech, M. et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. The Australian & New Zealand journal of obstetrics & gynaecology, 2009, 49, 3, p. 242–246.

86. Bergum, D., Lonnee, H., Hakli, T. F. Oxytocin infusion: acute hyponatraemia, seizures and coma. Acta Anaesthesiol Scand, 2009, 53, 6, p. 826–827.

87. Dansereau, J., Joshi, A. K., Helewa, M. E., Doran, T. A., Lange, I. R., Luther, E. R., Farine, D., Schulz, M. L., Horbay, G. L., Griffin, P. et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. American journal of obstetrics and gynekology, 1999, 180, 3 Pt 1, p. 670–676.

88. Mukaddam-Daher, S., Yin, Y. L., Roy, J., Gutkowska, J., Cardinal, R. Negative inotropic and chronotropic effects of oxytocin. Hypertension, 2001, 38, 2, p. 292–296.

89. Svanstrom, M. C., Biber, B., Hanes, M., Johansson, G., Naslund, U., Balfors, E. M. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. British journal of anaesthesia, 2008, 100, 5, p. 683–689.

90. Jonsson, M., Hanson, U., Lidell, C., Norden-Lindeberg, S. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology, 2010, 117, 1, p. 76–83.

91. Dogan, R., Birdane, A., Bilir, A., Ekemen, S., Tanriverdi, B. Frequency of electrocardiographic changes indicating myocardial ischemia during elective cesarean delivery with regional and general anesthesia: detection based on continuous Holter monitoring and serum markers of ischemia. Journal of clinical anesthesia, 2008, 20, 5, p. 347–351.

92. Dyer, R. A., Butwick, A. J., Carvalho, B. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Current opinion in anaesthesiology, 2011, 24, 3, p. 255–261.

93. Thomas, J. S., Koh, S. H., Cooper, G. M. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. British journal of anaesthesia, 2007, 98, 1, p. 116–119.

94. Langesaeter, E., Rosseland, L. A., Stubhaug, A. Haemo-dynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients. British journal of anaesthesia, 2009, 103, 2, p. 260–262.

95. Abdul-Karim, R., Assali, N. S. Renal function in human pregnancy. V. Effects of oxytocin on renal hemodynamics and water and electrolyte excretion. The Journal of laboratory and clinical medicine, 1961, 57, p. 522–532.

96. Carvalho, J. C., Balki, M., Kingdom, J., Windrim, R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstetrics and gynekology, 2004, 104, 5 Pt 1, p. 1005–1010.

97. Butwick, A. J., Coleman, L., Cohen, S. E., Riley, E. T., Carvalho, B. Minimum effective bolus dose of oxytocin during elective Caesarean delivery. British journal of anaesthesia, 2010, 104, 3, p. 338–343.

98. Sartain, J. B., Barry, J. J., Howat, P. W., McCormack, D. I., Bryant, M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. British journal of anaesthesia, 2008, 101, 6, p. 822–826.

99. Dyer, R. A., Reed, A. R., van Dyk, D., Arcache, M. J., Hodges, O., Lombard, C. J., Greenwood, J., James, M. F. Hemodynamic effects of ephedrine, phenylephrine, and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery. Anesthesiology, 2009, 111, 4, p. 753–765.

100. Langesaeter, E., Dragsund, M., Rosseland, L. A. Regional anaesthesia for a Caesarean section in women with cardiac disease: a prospective study. Acta Anaesthesiol. Scand., 2010, 54, 1, p. 46–54.